Crop Biotech Update

A weekly summary of world developments in agri-biotech for developing countries, produced by the Global Knowledge Center on Crop Biotechnology, International Service for the Acquisition of Agri-biotech Applications SEAsiaCenter (ISAAA), and AgBiotechNet

December 12, 2003

In This Issue:

GM Seeds and Glyphosate to Reduce Chemical Market
Research Proves Bt Gene Pyramiding Helps Prevent Pest Resistance
Biotech Crops Provide Economic Benefits
New Report on Use of GM Crops in Developing Countries
GM Trials Show Evidence of Co-Existence
Lithuania’s Food Import Procedures
Developing Countries and Uncertainties in Biosafety Laws
Announcement:
Conko: Familiar Phenotypes Need Less Biosafety Scrutiny
New Master’s Program: “The Agrifood Chain”

 

GM SEEDS AND GLYPHOSATE TO REDUCE CHEMICAL MARKET

Farmer expenditures for crop protection chemicals for corn, cotton, and soybeans are expected to decrease by more than $1 billion over the next five years. This is the prediction of a recently published study by the international consultancy firm Kline and Company due to increasing adoption of herbicide-tolerant and insect-resistant seeds as well as lower prices for glyphosate herbicide.

BIOTECH 2012 Business Analysis says the introduction of several new insect resistance genes for corn over the next few years will greatly reduce the need for insecticides to control corn rootworm, cutworm, and armyworm. Kline's study predicts sales of conventional insecticides for corn to decrease from $300 million in 2002 to $70 million in 2012. "This effectively turns the largest single-pest insecticide market into a smaller specialty market," says Mancer Cyr, senior associate in Kline’s Agribusiness Practice.

Cyr adds that there are more attractive opportunities to develop entirely new businesses based on value-added traits for food, industrial, and pharmaceutical uses. "For firms that are still dealing only in chemicals and haven't started exploring GM seed, their days as major basic suppliers could be numbered," says Cyr. "There could be room for them as niche suppliers as long as the niches are small enough to discourage new biotech inroads and large enough to keep the businesses afloat."

For more information, e-mail Kline and Company at: consult@klinegroup.com or visit their website at http://www.klinegroup.com/


BIOTECH CROPS PROVIDE ECONOMIC BENEFITS

Plant biotechnology is creating high-paying jobs and economic value and will deliver even more value for both farmers and other stakeholders in the agrifood chain. This was the conclusion of a study by C. Ford Runge, a professor at the University of Minnesota and director of the Center for International Food and Agricultural Policy.

According to the Council for Biotechnology Information, the study entitled "The Economic States and Performance of Plant Biotechnology in 2003: Adoption, Research and Development in the United States," is an up-to-date effort to provide a detailed view of biotechnology's value at the farm level and beyond the farm gate.

The U.S. Corn Belt and cotton-growing regions gained the most economic value from planting biotech crops in 2002, led by Iowa ($3.8 billion), Illinois ($2.5 billion), Minnesota ($2.2 billion), Nebraska ($1.8 billion), Indiana ($1.3 billion) and South Dakota ($1 billion).

Runge noted that aside from the more than $20 billion in biotech crops grown in 2002, new plant biotech firms and research facilities are being created throughout the US. The number of agricultural and food scientists were also found to be increasing and that more states are reaping the benefits of this investment and job-related activities.

The study is available online at http://www.apec.umn.edu/faculty/frunge/plantbiotech.pdf.


GM TRIALS SHOW EVIDENCE OF CO-EXISTENCE

Evidence show that conventional and organic crops have co-existed with genetically modified (GM) trial crops without any economic and commercial problems. Also, the adventitious presence of GMOs were absent in conventional and organic crops that were located near the transgenic crops. These were the highlights of the recent study conducted by Graham Brookes and Peter Barfoot entitled “Co-existence of GM and non GM arable crops: case study of the United Kingdom.”

In this paper, Brookes and Barfoot examined the issue of co-existence of GM and non-GM crops, focusing on the main arable crops grown in the UK. At present, no GM crops are grown commercially in the UK, however 260 Farm Scale Evaluation field trials (FSEs) have been conducted for the past three years for crops such as oilseed rape, sugar beet and forage maize. These FSEs covered about 1,220 hectares (an annual average of 405 hectares) as compared to the 693,000 hectares planted to the three crops previously mentioned, 99.76% of which is conventionally produced and 0.24% is organic.

Lastly, the authors emphasized the importance of “context” and “proportionality.” They considered it disproportionate and inequitable if difficult GM crop stewardship conditions would be imposed to farms that might wish to grow GM crops, even though they are not located near conventional or organic crops. Thus, majority of the conventional farmers (99.76%) could be discouraged from adopting a technology that could have farm level benefits (yield gains, cost savings), and provide wider environmental gains (reduced pesticide use, usage of more environmentally benign herbicides, reduced levels of greenhouse gas emissions).

The full paper is available at http://www.isaaa.org/kc.


DEVELOPING COUNTRIES AND UNCERTAINTIES IN BIOSAFETY LAWS

With the implementation of the Cartagena Protocol on Biosafety, developing countries now face challenges on how to address several issues left to national discretion, and how to balance their rights and obligations in accordance with their commitments to the World Trade Organization (WTO).

According to Ruth Mackenzie of the Institute of Development Studies in Brighton, United Kingdom, and Dominic Glover, a primary issue faced by developing countries is the development and implementation of the national biosafety frameworks that deal with the importations of genetically modified organisms (GMOs) and GM commodities. Another consideration is on how to best incorporate the precautionary principle and socio-economic considerations of the Protocol into the national decision-making process.

The authors added that developing countries are also likely to become susceptible to pressures for harmonization applied via diplomatic channels, through bilateral trade, and investments. Given this diversity of conditions, interests, experience, and capacity, Mackenzie and Glover suggested that developing countries employ additional flexibility in the application of international trade disciplines with regards to the assessment of biosafety measures.

Harmonizing national diversity in the advent of a new technology is a challenge itself to the national biosafety authorities, and the entire international trade regime, concludes the authors.

Download the paper entitled “Harmonization, Diversity and Uncertainty in International Biosafety Regulation” at http://www.ids.ac.uk/ids/env/PDFs/%20Briefing6.pdf.


CONKO: FAMILIAR PHENOTYPES NEED LESS BIOSAFETY SCRUTINY

The precautionary principle has led to an inappropriate level of biosafety scrutiny for genetically modified (GM) plants with transgenes with a history of safe use, argues Gregory Conko of the Competitive Enterprise Institute. In a paper in Transgenic Research, he stresses that the precautionary approach does not give a clear picture of what information is needed to make a risk assessment. The precautionary principle (PP) and precautionary approach "are public policy tools, not scientific ones," says Conko.

Conko says that the PP entails making a decision based on how much information is available and that certain experiments, production and commercialization processes cannot proceed without express permission from a government authority. He notes that standards for evaluation could vary, since there's no established or widely accepted definition of how much data one needs to make an approval decision."The problem is not just that different regulatory authorities might have different standards, but rather that a single regulatory agency could apply different standards to similar products," adds Conko.

Giving governments so much subjective discretionary authority allows "politics" and other biases to affect the regulatory process. Conko explains that this might slow down innovation and the introduction of new technologies.

The paper recommends a tiered set of regulatory standards for different risk classes of transgenic organisms. Conko says there is a need to re-think about the regulation of transgenic organisms. He suggests that in cases where specific transgenes are known to be environmentally benign and safe for human and animal consumption.

The paper, "Safety, Risk and the Precautionary Principle: Rethinking Precautionary Approaches to the Regulation of Transgenic Plants" by Gregory Conko appears in Transgenic Research 12 (6): 639-647 or at this site http://dx.doi.org/doi:10.1023/B:TRAG.0000005157.45046.8e ; or email Gregory Conko at gconko@cei.org for more information.


RESEARCH PROVES BT GENE PYRAMIDING HELPS PREVENT PEST RESISTANCE

Researchers at Cornell University have provided the first experimental evidence that breeding plants to produce two different proteins by a process called "gene pyramiding" delays the development of resistance in targeted insect pests. The research has important implications for the long-term protection of agricultural crops produced through biotechnology, particularly Bt corn and Bt cotton.

Resistance was compared under several different management strategies. "Plants containing two Bt toxin genes substantially delayed the development of resistance compared to two single-toxin plants used sequentially or in a mosaic," said Shelton. "Regulatory agencies and companies now should work together to promote the development of these pyramid plants and, in the long term, phase out single gene plants."

Mathematical models of insect resistance suggest that plants with genes for two different Bt toxins would delay resistance longer than planting a mixture of two single-toxin plants in the field or using two single-toxin plants sequentially in crop rotation. This research provides the first experimental confirmation of the value of dual-toxin plants.

A full report of the work entitled, "Transgenic plants Expressing Two Bacillus thuringiensis (Bt) Toxins Delay Insect Resistance Evolution," is published in Nature Biotechnology.

For further details email Anthony Shelton at ams5@cornell.edu.


NEW REPORT ON USE OF GM CROPS IN DEVELOPING COUNTRIES

Genetically modified (GM) crops of relevance to poor third-world farmers can be expected within the next 5-10 years. Hence, development aid organizations must prepare poor developing nations to properly handle GM crops regardless of whether the organizations recommend introducing such crops or not.

These were among the recommendations made in the report "Genetically Modified Crops in Developing Countries - Challenges for the Development Aid" written by an interdisciplinary task force appointed by The Danish Board of Technology. The Board has facilitated a yearlong assessment of the pros and cons of using GM to fight poverty and hunger in the third world.

The task force urges all development aid organizations to assist developing countries in the task of building up the proper institutional capacity to make their own assessments of genetically modified crops through:

  • the establishment of and cooperation with representative, efficient and legitimate agricultural organizations;
  • the establishment of relevant public institutions and organizations responsible for everything from legislation to assessment of technology and management of environmental problems;
  • ensuring the ability to enforce laws and regulations relative to the handling of GM crops; and
  • ensuring support for research into GM crops in the developing countries.

The summary can be viewed online at http://www.tekno.dk/pdf/projekter/
p03_gen_mod_crops_summary.pdf

Any questions concerning the summary can be directed to Project Manager Søren Gram at sg@tekno.dk.


LITHUANIA’S FOOD IMPORT PROCEDURES

The United States Department of Agriculture Foreign Agricultural Services (USDA-FAS) has released a country report on the current food and agricultural import regulations and standards that are currently in place in Lithuania. These new laws and regulations are seen to be beneficial to exporters.

Prepared by the International Business Network, the report discusses detailed information regarding Lithuania’s import procedures including food laws, labeling requirements, packaging and container regulations, recycling requirements, food additive regulations, regulations on pesticides and other contaminants, and other laws pertinent to the food industry.

Lithuania will formally become a member of the European Union (EU) in May 2004. It is also one of the countries of the former Soviet bloc that have adopted regulations consistent with those in place in the EU.

Read the country report in detail at http://www.fas.usda.gov/gainfiles/
200311/145986793.pdf
.


ANNOUNCEMENT:


NEW MASTER’S PROGRAM: “THE AGROFOOD CHAIN”

The Universities of Toulouse and the AGROMIP consortium are launching in September 2004 in Toulouse a two-year multidisciplinary Master course in Agrobiosciences, entirely in English and open to students worldwide : "THE AGROFOOD CHAIN - Innovations for a sustainable agriculture and better products". Further information is available on the web site: http://www.agromip.educagri.fr. 

Do not hesitate to tell other colleagues/contacts about this mail list. If they wish to join, they should send an e-mail message to knowledge.center@isaaa.org leaving the subject blank and entering the one-line text message as follows: SUBSCRIBE Crop Biotech Network

To stop receiving this newsletter, please send an e-mail message to knowledge.center@isaaa.org and write, "unsubscribe newsletter" in the subject box.

Please visit CropBiotech Net web pages (http://www.isaaa.org/kc) to view previous issues of this newsletter and see other available resources for download.

While we are still developing this site, feel free to e-mail (knowledge.center@isaaa.org) us for your views and comments on any crop biotechnology product and related issues.
Home :: Global Status :: CBT Update :: Info Resource :: Events :: BICs :: Directory :: About Us :: Editorial Policy

Copyright © 2006. CropBiotech Net.